JARID2 and hepatocellular carcinoma: In summary, we demonstrated that EZH2/JARID2 has a significant and specific preference to bind to the highly expressed and cancer-related genes in the HepG2 cell line, which may partially explain the contribution of EZH2/JARID2 in the carcinogenesis and progression of HCC.